This article is more than 5 years old. Information may no longer be current.
Arthrosurface granted FDA clearance for new suture system
Click Here to Manage Email Alerts
Arthrosurface recently announced it has received FDA 510(k) clearance for the new KISSloc Suture System for use in bunion deformity fixations.
The all-disposable system consists of two low-profile plates and a self-cinching suture construct that corrects bunion deformity by reducing the intramedullary angle between the first and second metatarsal bones. Bunion correction can be achieved with one KISSloc construct as opposed to two separate suture bridges, increasing ease of use while decreasing cost, according to a company press release.
Arthrosurface believes the KISSloc Suture system will help minimize stress fractures of the second metatarsal, recently associated with suture-button bunion fixation, by allowing more accurate bone tunnel placement, utilizing smaller bone tunnels and a more robust suture.
The KISSloc Suture System is currently scheduled for a commercial release before the end of 2014.